Aggravated infection in mice co-administered with Mycobacterium tuberculosis and the 27-kDa lipoprotein

Microbes and Infection

Volumn 8, Issue 7, 2006, Pages 1750-1757

  Hovav, Avi Hai ^a   Mullerad, Jacob ^a   Maly, Alexander ^a   Davidovitch, Liuba ^a   Fishman, Yolanta ^a   Bercovier, Herve ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Immunosuppression; Lipoprotein; Mycobacterium; Tuberculosis

Indexed keywords

CONCANAMYCIN A; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; LIPOPROTEIN; N(G) METHYLARGININE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DISEASE EXACERBATION; FEMALE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION SENSITIVITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; INTERFERON TYPE II; LIPOPROTEINS; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; SPLEEN; TUBERCULIN; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 33746436594     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.02.011     Document Type: Article

References (20)

1. Bigi F., Espitia C., Alito A., Zumarraga M., Romano M.-I., Cravero S., and Cataldi A. A novel 27 kDa lipoprotein antigen from Mycobacterium bovis. Microbiology 143 (1997) 3599-3605
2. Hovav A.-H., Mullerad J., Davidovitch L., Fishman Y., Bigi F., Cataldi A., and Bercovier H. The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection. Infect. Immun. 71 (2003) 3146-3154
3. Hovav A.-H., Davidovitch L., Nussbaum G., Mullerad J., Fishman Y., and Bercovier H. Mitogenicity of the recombinant mycobacterial 27-kilodalton lipoprotein is not connected to its antiprotective effect. Infect. Immun. 72 (2004) 3383-3390
4. Gehring A.-J., Dobos K.-M., Belisle J.T., Harding C.-V., and Boom W.-H. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 173 (2004) 2660-2668
5. Bigi F., Gioffre A., Klepp L., de la Paz Santangelo M., Alito A., Caimi K., Meikle V., Zumarraga M., Taboga O., Romano M.-I., and Cataldi A. The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis. Microbes Infect. 6 (2004) 182-187
6. Abou-Zeid C., Gares M.-P., Inwald J., Janssen R., Zhang Y., Young D.-B., Hetzel C., Lamb J.-R., Baldwin S.L., Orme I.-M., Yeremeev V., Nikonenko B.-V., and Apt A.-S. Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect. Immun. 65 (1997) 1856-1862
7. E-Noss H., Pai R.-K., Sellati T.-J., Radolf J.-D., Belisle J., Golenbock D.-T., Boom W.-H., and Harding C.-V. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167 (2001) 910-918
8. Zhang H., Niesel D.-W., Peterson J.-W., and Klimpel G.-R. Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect. Immun. 66 (1998) 5196-5201
9. Green L.-C., Wagner D.-A., Glogowski J., Skipper P.-L., Wishnok J.-S., and Tannenbaum S.-R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
10. Brightbill H.-D., Libraty D.-H., Krutzik S.-R., Yang R.-B., Belisle J.-T., Bleharski J.-R., Maitland M., Norgard M.-V., Plevy S.-E., Smale S.-T., Brennan P.-J., Bloom B.-R., Godowski P.-J., and Modlin R.-L. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285 (1999) 732-736
11. Cooper A.-M., Adams L.-B., Dalton D.-K., Appelberg R., and Ehlers S. IFN-gamma and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol. 10 (2002) 221-226
12. Kremer L., Estaquier J., Wolowczuk I., Biet F., Ameisen J.-C., and Locht C. Ineffective cellular immune response associated with T-cell apoptosis in susceptible Mycobacterium bovis BCG-infected mice. Infect. Immun. 68 (2000) 4264-4273
13. Dalton D.-K., Haynes L., Chu C.-Q., Swain S.-L., and Wittmer S. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J. Exp. Med. 192 (2000) 117-122
14. Nabeshima S., Nomoto M., Matsuzaki G., Kishihara K., Taniguchi H., Yoshida S., and Nomoto K. T-Cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis. Infect. Immun. 67 (1999) 3221-3226
15. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.-T., Engele M., Sieling P.-A., Barnes P.-F., Rollinghoff M., Bolcskei P.-L., Wagner M., Akira S., Norgard M.-V., Belisle J.-T., Godowski P.-J., Bloom B.-R., and Modlin R.-L. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291 (2001) 1544-1547
16. Drennan M.-B., Nicolle D., Quesniaux V.-J., Jacobs M., Allie N., Mpagi J., Fremond C., Wagner H., Kirschning C., and Ryffel B. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am. J. Pathol. 164 (2004) 49-57
17. Sander P., Rezwan M., Walker B., Rampini S.-K., Kroppenstedt R.-M., Ehlers S., Keller C., Keeble J.-R., Hagemeier M., Colston M.-J., Springer B., and Bottger E.-C. Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 52 (2004) 1543-1552
18. Bronstein-Sitton N., Cohen-Daniel L., Vaknin I., Ezernitchi A.-V., Leshem B., Halabi A., Houri-Hadad Y., Greenbaum E., Zakay-Rones Z., Shapira L., and Baniyash M. Sustained exposure to bacterial antigen induces interferon-gamma-dependent T cell receptor zeta down-regulation and impaired T cell function. Nat. Immunol. 4 (2003) 957-964
19. Zganiacz A., Santosuosso M., Wang J., Yang T., Chen L., Anzulovic M., Alexander S., Gicquel B., Wan Y., Bramson J., Inman M., and Xing Z. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 113 (2004) 401-413
20. Rao V., Dhar N., Shakila H., Singh R., Khera A., Jain R., Naseema M., Paramasivan C.-N., Narayanan P.-R., Ramanathan V.-D., and Tyagi A.-K. Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype. Scand. J. Immunol. 61 (2005) 410-417